Atopic dermatitis

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Jul 2006 English Publisher:Elsevier BVJournal:Journal of Allergy and Clinical Immunology, volume 118, pages 40-43 (issn: 0091-6749,

Copyright policy )

Authors: Mark, Boguniewicz; Peter, Schmid-Grendelmeier; Donald Y M, Leung;

doi: 10.1016/j.jaci.2006.04.044

pmid: 16815136

Atopic dermatitis

- Summary
- Subjects
- Metrics

Related Organizations

National Jewish Health
United States
University of Colorado Cancer Center
United States
University Hospital of Zurich
Switzerland

Keywords

Calcineurin Inhibitors, Antibodies, Monoclonal, Omalizumab, Antibodies, Monoclonal, Humanized, Antibodies, Anti-Idiotypic, Dermatitis, Atopic, Recurrence, Histamine H1 Antagonists, Humans, Immunotherapy, Skin Diseases, Infectious, Food Hypersensitivity, Skin Tests

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	97
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%